| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5020631 | Journal of the Mechanical Behavior of Biomedical Materials | 2017 | 9 Pages |
Abstract
Compared to modern THR in clinical practice that shows survival rates of 10, 15, 20 or more years, the receivable bond strength enhancements described in this study appeared to be very short. The improved SBS on THR alloys lasted only a few days before it was lost again. In contrast, the phosphoric acid primer treatment of polished Sn appeared to be very promising and may play a key role in further investigations dealing with the prevention of the stem-cement debonding in THR.
Related Topics
Physical Sciences and Engineering
Engineering
Biomedical Engineering
Authors
Eike Jakubowitz, Louisa Liehn, Alexander Jahnke, Bernd Wöstmann, Markus Rickert, Thomas Niem,